Consolidated Statement of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
OPERATING ACTIVITIES
Net income (loss)	$ 26,209	$ (11,968)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Provision for credit losses	257	9,295
Depreciation	1,892	1,121
Amortization of intangible assets	4,778	663
Accretion of discounts, net	(11,747)	(204)
Origination of loans to be sold	(10,093)	(4,210)
Proceeds from loan sales	10,363	4,537
Gain on sale of loans	(270)	(465)
Share-based and deferred compensation	1,864	1,049
Bank-owned life insurance income	(1,633)	(738)
(Gain) loss on sale of debt securities	(4)	2,370
Change in accrued interest receivable and other assets	5,939	(3,800)
Change in accrued interest payable and other liabilities	(1,977)	2,340
Other, net	(136)
Net cash provided by (used in) operating activities	25,442	(10)
Investment securities available for sale:
Proceeds from sales	1,691	91,364
Proceeds from calls and maturities	10,230
Proceeds from principal repayments	13,255	8,285
Purchases	(57,322)	(9,756)
Investment securities held to maturity
Proceeds from principal repayments	5,055	3,436
Purchases	(250)	(11,289)
Proceeds from redemptions of certificates of deposit with other banks	0	5,623
Purchase of restricted investment in bank stocks	(16,530)	(15,624)
Redemption of restricted investment in bank stocks	15,286	21,799
Increase in loans, net	(91,433)	(65,915)
Purchase of bank-owned life insurance	(1,599)	(9,712)
Cash paid to buy-out minority interest	(483)
Proceeds from disposal of premises and equipment	2,967
Purchase of premises and equipment	(2,885)	(1,153)
Purchase of computer software		(220)
Net cash acquired through merger and acquisition		41,745
Net cash (used in) provided by investing activities	(122,018)	58,583
FINANCING ACTIVITIES
Increase in deposits, net	153,425	51,834
Change in short-term borrowings, net	0	(65,640)
Proceeds from long-term borrowings	40,000	0
Issuance of shares from exercise of stock options	14	150
Dividends paid	(11,105)	(4,870)
Net proceeds from issuance of common stock	152	10,132
Net cash provided by (used in) financing activities	182,486	(8,394)
Increase in cash and cash equivalents	85,910	50,179
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	80,190	30,011
CASH AND CASH EQUIVALENTS AT END OF PERIOD	166,100	80,190
SUPPLEMENTAL CASH FLOW DISCLOSURES
Interest	58,431	27,874
Income taxes	0	0
Reclassification of New Jersey branch loans from portfolio loans to assets held-for-sale, net	(21,528)
Reclassification of New Jersey branch assets to assets held-for-sale	175
Reclassification of New Jersey branch deposits to liabilities held-for-sale, net	6,124
Reclassification of New Jersey branch liabilities to liabilities held-for-sale	$ (124)
Non-cash assets acquired:
Securities available for sale		123,440
Loans		1,240,334
Investments in restricted bank stock		6,763
Premises and equipment		15,504
Right-of-Use Asset		6,042
Bank-owned life insurance		19,153
Goodwill		21,126
Intangible Assets		25,344
Deferred tax assets		14,466
Accrued interest receivable and other assets		10,730
Liabilities assumed:
Deposits		1,299,867
Other borrowings		55,292
Subordinated debt		21,078
Operating lease liabilities		6,908
Accrued interest payable and other liabilities		5,724
Net non-cash assets acquired		94,033
Cash and cash equivalents acquired		$ 41,745